A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Public ClinicalTrials.gov record NCT07300267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Randomized, Double-Blind, Active Comparator Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Novel Pneumococcal Vaccine in Children
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Researchers are looking for new vaccines to prevent pneumococcal disease, which is any infection in the lungs or other parts of the body that is caused by a type of bacteria called Streptococcus pneumoniae. V118C is a new vaccine designed to help prevent disease from Streptococcus pneumoniae bacteria. This study will look at V118C in toddlers and infants. The goal of the study is to learn how safe V118C is for children and how well they tolerate it.
Study identification
- NCT ID
- NCT07300267
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 210 participants
Conditions and interventions
Conditions
Interventions
- V118C (Stage 1) Biological
- V118C (Stage 2) Biological
- PCV20 (Stage 1) Biological
- PCV20 (Stage 2) Biological
Biological
Eligibility (public fields only)
- Age range
- 2 Months to 15 Months
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 12, 2026
- Primary completion
- Oct 23, 2028
- Completion
- May 24, 2029
- Last update posted
- Apr 16, 2026
2026 – 2029
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Madera Family Medical Group ( Site 1004) | Madera | California | 93637 | Recruiting |
| Acevedo Clinical Research Associates ( Site 1029) | Miami | Florida | 33142 | Recruiting |
| University of South Florida-Department of Pediatrics ( Site 1002) | Tampa | Florida | 33606 | Recruiting |
| Cotton O'Neil Research Center ( Site 1039) | Topeka | Kansas | 66604 | Recruiting |
| University of Louisville, Norton Children's Research Institute ( Site 1005) | Louisville | Kentucky | 40202 | Recruiting |
| The Pediatric Center ( Site 1025) | Columbia | Maryland | 21045 | Recruiting |
| Saint Louis University Center for Vaccine Development ( Site 1031) | St Louis | Missouri | 63104 | Recruiting |
| Child Health Care Associates ( Site 1035) | East Syracuse | New York | 13057 | Recruiting |
| Tribe Clinical Research, LLC-Pediatrics ( Site 1008) | Greenville | South Carolina | 29607 | Recruiting |
| Tribe Clinical Research - Spartanburg ( Site 1001) | Spartanburg | South Carolina | 29301 | Recruiting |
| Epic Medical Research - Carrollton ( Site 1038) | Carrollton | Texas | 75006 | Recruiting |
| Epic Medical Research- Garland ( Site 1017) | Garland | Texas | 75043 | Recruiting |
| University of Texas Medical Branch ( Site 1020) | League City | Texas | 77573 | Recruiting |
| Pediatric Research of Charlottesville, LLC ( Site 1012) | Charlottesville | Virginia | 22902 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07300267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07300267 live on ClinicalTrials.gov.